Targeted quantification of N-1-(carboxymethyl) valine and N-1-(carboxyethyl) valine peptides of [beta]-hemoglobin for better diagnostics in diabetes

Background N-1-(Deoxyfructosyl) valine (DFV) [beta]-hemoglobin ([beta]-Hb), commonly referred as HbA1c, is widely used diagnostic marker in diabetes, believed to provide glycemic status of preceding 90-120 days. However, the turnover of hemoglobin is about 120 days, the DFV-[beta]-Hb, an early and r...

Full description

Saved in:
Bibliographic Details
Published inClinical proteomics Vol. 13; no. 1
Main Authors Tiwari, Shalbha, Unnikrishnan, Ambika G, Batkulwar, Kedar B, Meshram, Nishita N, Kulkarni, Mahesh J, Korwar, Arvind M, Jagadeeshaprasad, Mashanipalya G
Format Journal Article
LanguageEnglish
Published BioMed Central Ltd 29.03.2016
Subjects
Care and treatment
Diabetes
Diagnosis
Genetic aspects
Peptides
Physiological aspects
Prediabetic state
India
Online AccessGet full text

Cover

More Information
Summary:Background N-1-(Deoxyfructosyl) valine (DFV) [beta]-hemoglobin ([beta]-Hb), commonly referred as HbA1c, is widely used diagnostic marker in diabetes, believed to provide glycemic status of preceding 90-120 days. However, the turnover of hemoglobin is about 120 days, the DFV-[beta]-Hb, an early and reversible glycation product eventually may undergo irreversible advanced glycation modifications such as carboxymethylation or carboxyethylation. Hence quantification of N-1-(carboxymethyl) valine (CMV) and N-1-(carboxyethyl) valine (CEV) peptides of [beta]-Hb would be useful in assessing actual glycemic status. Results Fragment ion library for synthetically glycated peptides of hemoglobin was generated by using high resolution-accurate mass spectrometry (HR/AM). Using parallel reaction monitoring, deoxyfructosylated, carboxymethylated and carboxyethylated peptides of hemoglobin were quantified in clinical samples from healthy control, pre-diabetes, diabetes and poorly controlled diabetes. For the first time, we report N-1-[beta]-valine undergoes carboxyethylation and mass spectrometric quantification of CMV and CEV peptides of [beta]-hemoglobin. Carboxymethylation was found to be the most abundant modification of N-1-[beta]-valine. Both CMV-[beta]-Hb and CEV-[beta]-Hb peptides showed better correlation with severity of diabetes in terms of fasting glucose, postprandial glucose and microalbuminuria. Conclusions This study reports carboxymethylation as a predominant modification of N-1-[beta]-valine of Hb, and quantification of CMV-[beta]-Hb and CEV-[beta]-Hb could be useful parameter for assessing the severity of diabetes. Keywords: Diabetes, Diagnosis, Glycation, Glycemic control, HbA1c, Mass spectrometry
ISSN:1542-6416